Literature DB >> 21339855

Battling with environments: drug delivery to target tissues with particles and functional biomaterials.

Yoon Yeo1.   

Abstract

Recent years have seen a growing interest in drug-delivery technology as an enabling tool for complicated pharmacological activities. At the same time, this field has faced as many challenges as successes in translating novel ideas into clinical benefits. The Laboratory for Therapeutic Particles and Biomaterials Engineering at Purdue University (IN, USA) has striven to identify the current challenges in drug delivery and find solutions through the design of new drug-delivery systems. We develop new inhalable formulations for drug and gene delivery for cystic fibrosis patients, simple particle platforms for inhalable drug delivery, anion-resistant nonviral gene vectors, tumor-targeted nanoparticle systems, and hydrogel-based therapeutics. Through expanded collaborations with researchers in medicine and related disciplines, we strive to contribute to advancing the drug delivery field in a clinically relevant manner.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21339855      PMCID: PMC3041594          DOI: 10.4155/tde.10.80

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  18 in total

1.  Drug and gene delivery to mucosal tissues: the mucus barrier. Preface.

Authors:  Justin Hanes; Jo Demeester
Journal:  Adv Drug Deliv Rev       Date:  2009-02-27       Impact factor: 15.470

2.  Gene delivery through the use of a hyaluronate-associated intracellularly degradable crosslinked polyethyleneimine.

Authors:  Peisheng Xu; Griffin K Quick; Yoon Yeo
Journal:  Biomaterials       Date:  2009-07-25       Impact factor: 12.479

3.  Large porous particles for pulmonary drug delivery.

Authors:  D A Edwards; J Hanes; G Caponetti; J Hrkach; A Ben-Jebria; M L Eskew; J Mintzes; D Deaver; N Lotan; R Langer
Journal:  Science       Date:  1997-06-20       Impact factor: 47.728

4.  Differential effects of insufflated, subcutaneous, and intravenous growth hormone on bone growth, cognitive function, and NMDA receptor subunit expression.

Authors:  Sung Won Park; Sooyoung Shin; Chi Hwa Kim; Ah-ra Ko; Min Jung Kwak; Mi Hyun Nam; So Young Park; Su Jin Kim; Young Bae Sohn; Raymond E Galinsky; Hojoong Kim; Yoon Yeo; Dong-Kyu Jin
Journal:  Endocrinology       Date:  2010-07-07       Impact factor: 4.736

Review 5.  Drug delivery systems for intraperitoneal therapy.

Authors:  Gaurav Bajaj; Yoon Yeo
Journal:  Pharm Res       Date:  2010-03-03       Impact factor: 4.200

6.  Zwitterionic chitosan derivatives for pH-sensitive stealth coating.

Authors:  Peisheng Xu; Gaurav Bajaj; Tyler Shugg; William G Van Alstine; Yoon Yeo
Journal:  Biomacromolecules       Date:  2010-09-13       Impact factor: 6.988

7.  Inhalable antibiotic delivery using a dry powder co-delivering recombinant deoxyribonuclease and ciprofloxacin for treatment of cystic fibrosis.

Authors:  Yan Yang; Michael D Tsifansky; Chia-Jung Wu; Hae In Yang; Gudrun Schmidt; Yoon Yeo
Journal:  Pharm Res       Date:  2009-10-22       Impact factor: 4.200

8.  Development of inhalable dry powder formulation of basic fibroblast growth factor.

Authors:  Basma M Ibrahim; Seoung Wook Jun; Mee Yong Lee; Soo Hyung Kang; Yoon Yeo
Journal:  Int J Pharm       Date:  2009-10-21       Impact factor: 5.875

9.  Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited.

Authors:  Peisheng Xu; Emily Gullotti; Ling Tong; Christopher B Highley; Divya R Errabelli; Tayyaba Hasan; Ji-Xin Cheng; Daniel S Kohane; Yoon Yeo
Journal:  Mol Pharm       Date:  2009 Jan-Feb       Impact factor: 4.939

Review 10.  Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery.

Authors:  Emily Gullotti; Yoon Yeo
Journal:  Mol Pharm       Date:  2009 Jul-Aug       Impact factor: 4.939

View more
  2 in total

1.  Novel Span-PEG Multifunctional Ultrasound Contrast Agent Based on CNTs as a Magnetic Targeting Factor and a Drug Carrier.

Authors:  Jie Zhang; Zhongtao Liu; Shujing Zhou; Yang Teng; Xiangyu Zhang; Jinjing Li
Journal:  ACS Omega       Date:  2020-12-01

2.  The Biocomplex Assembled from Antigen Peptide and Toll-like Receptor Agonist Improved the Immunity against Pancreatic Adenocarcinoma In Vivo.

Authors:  Wenming Feng; Hongbin Yu; Tao Xue; Chunyong Wu; Fan Ren; Ge Cui
Journal:  J Oncol       Date:  2022-08-25       Impact factor: 4.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.